GP9

Chr 3AR

glycoprotein IX platelet

Also known as: CD42a, GPIX

This gene encodes a small membrane glycoprotein found on the surface of human platelets. It forms a 1-to-1 noncovalent complex with glycoprotein Ib, a platelet surface membrane glycoprotein complex that functions as a receptor for von Willebrand factor. The complete receptor complex includes noncovalent association of the alpha and beta subunits with the protein encoded by this gene and platelet glycoprotein V. Defects in this gene are a cause of Bernard-Soulier syndrome, also known as giant platelet disease. These patients have unusually large platelets and have a clinical bleeding tendency. [provided by RefSeq, Oct 2008]

OMIMResearchGenerating clinical summary…
GOFmechanismARLOEUF 1.461 OMIM phenotype
Clinical SummaryGP9
🧬
Gene-Disease Validity (ClinGen)
Bernard-Soulier syndrome · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.00) despite low pLI — interpret in context.
📋
ClinVar Variants
29 unique Pathogenic / Likely Pathogenic· 59 VUS of 169 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
1.46LOEUF
pLI 0.476
Z-score 1.22
OE 0.00 (0.001.46)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?
0.16Z-score
OE missense 0.96 (0.821.12)
109 obs / 113.9 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.00 (0.001.46)
00.351.4
Missense OE?0.96 (0.821.12)
00.61.4
Synonymous OE?1.08
01.21.6
LoF obs/exp: 0 / 1.7Missense obs/exp: 109 / 113.9Syn Z: -0.47

This gene — mechanism propensity

DN
0.5770th %ile
GOF
0.73top 25%
LOF
0.3941th %ile

The highest-scoring mechanism for this gene is gain-of-function.

GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

169 submitted variants in ClinVar

Classification Summary

Pathogenic11
Likely Pathogenic18
VUS59
Likely Benign63
Benign10
Conflicting8
11
Pathogenic
18
Likely Pathogenic
59
VUS
63
Likely Benign
10
Benign
8
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
4
5
2
0
11
Likely Pathogenic
9
9
0
0
18
VUS
1
53
5
0
59
Likely Benign
0
4
2
57
63
Benign
0
3
4
3
10
Conflicting
8
Total14741360169

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

9 pathogenic / likely-pathogenic (of 15) ClinVar copy-number / structural variants overlap GP9 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

GP9 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →